Harfst & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-476
| Closed | -$221K | – | 98 |
|
|
2024
Q3 | $221K | Sell |
476
-546
| -53% | -$254K | 0.05% | 91 |
|
|
2024
Q2 | $479K | Hold |
1,022
| – | – | 0.11% | 80 |
|
|
2024
Q1 | $427K | Sell |
1,022
-14
| -1% | -$5.85K | 0.1% | 85 |
|
|
2023
Q4 | $422K | Hold |
1,036
| – | – | 0.11% | 68 |
|
|
2023
Q3 | $360K | Hold |
1,036
| – | – | 0.1% | 75 |
|
|
2023
Q2 | $365K | Sell |
1,036
-1,174
| -53% | -$413K | 0.1% | 77 |
|
|
2023
Q1 | $696K | Sell |
2,210
-7
| -0.3% | -$2.21K | 0.2% | 74 |
|
|
2022
Q4 | $640K | Sell |
2,217
-43
| -2% | -$12.4K | 0.18% | 76 |
|
|
2022
Q3 | $654K | Sell |
2,260
-21
| -0.9% | -$6.08K | 0.2% | 74 |
|
|
2022
Q2 | $642K | Sell |
2,281
-22
| -1% | -$6.19K | 0.18% | 78 |
|
|
2022
Q1 | $601K | Buy |
2,303
+405
| +21% | +$106K | 0.14% | 94 |
|
|
2021
Q4 | $416K | Sell |
1,898
-1,189
| -39% | -$261K | 0.11% | 97 |
|
|
2021
Q3 | $559K | Sell |
3,087
-109
| -3% | -$19.7K | 0.15% | 95 |
|
|
2021
Q2 | $644K | Buy |
3,196
+78
| +3% | +$15.7K | 0.19% | 91 |
|
|
2021
Q1 | $670K | Buy |
+3,118
| New | +$670K | 0.2% | 93 |
|